Evaluation of RC28-E Injection in Diabetic Macular Edema

NCT04782115 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

BIOLOGICAL: intravitreal injection of RC28-E
BIOLOGICAL: Conbercept

Sponsor

RemeGen Co., Ltd.